“RLD/Innovator Sourcing from India, Europe, USA, Japan Australia etc”
Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its regulatory submissions. Ikris can source and supply RLD’s as required (specific batches & expiries) on an international scale.
- Our experience combined with our international network of pharmaceutical drug wholesaler partners makes it possible for Ikris Pharma to procure branded Innovator Samples / Reference Listed Drugs for bioequivalence and clinical trials from almost anywhere in the world.
- Ikris specialized in sourcing branded Innovator Samples / Reference Listed Drugs (RLD) from single / multiple batches in specific quantities as well as ability to supply the products that are unavailable from most suppliers. We can source innovator sample from Different Global markets like USA, Europe, Australia, Canada, Japan, Brazil etc.
- Our experience with cold chain shipping and in dealing with international customs requirements helps us to ensure that temperature sensitive study drugs arrive to your clinical trial facilities within the required temperature range. We use dedicated transport companies that cater for cold, ambient and everyday storage and delivery requirements. Our team will provide regular updates and advise of product shortages or manufacturer delays enabling you to stay one step ahead and plan your study accordingly.
“Ikris, trusted to manage access of Innovator Medicines almost every therapeutic area for pharmaceutical companies, Patients, Healthcare professionals, Patient Groups and Pharmacist.”